ANDA 75659, held by Watson Labs. Nifedipine.
As of Nov 16, 2026, ANDA 75659 (Afeditab Cr), held by Watson Labs, was first approved by FDA on Oct 26, 2001, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 26, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Afeditab Cr60MG ยท tablet, extended release;oral | Nifedipine | Discontinued |
| May 3, 2005 | Supplement 8Labeling | Approved | None posted |
| Jun 18, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Apr 5, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Mar 15, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Oct 26, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters